H. E. Bostancı Et Al. , "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies," ARCHIV DER PHARMAZIE , vol.358, no.3, pp.2400930, 2025
Bostancı, H. E. Et Al. 2025. New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. ARCHIV DER PHARMAZIE , vol.358, no.3 , 2400930.
Bostancı, H. E., Yıldız, M. T., Kapancık, S., Şahin İnan, Z. D., Kılıç, H. A., Özensoy Güler, Ö., ... Acar Çevik, U.(2025). New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies. ARCHIV DER PHARMAZIE , vol.358, no.3, 2400930.
Bostancı, Hayrani Et Al. "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies," ARCHIV DER PHARMAZIE , vol.358, no.3, 2400930, 2025
Bostancı, Hayrani E. Et Al. "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies." ARCHIV DER PHARMAZIE , vol.358, no.3, pp.2400930, 2025
Bostancı, H. E. Et Al. (2025) . "New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies." ARCHIV DER PHARMAZIE , vol.358, no.3, p.2400930.
@article{article, author={Hayrani Eren Bostancı Et Al. }, title={New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies}, journal={ARCHIV DER PHARMAZIE}, year=2025, pages={2400930} }